0000930413-11-002543.txt : 20110405 0000930413-11-002543.hdr.sgml : 20110405 20110405170322 ACCESSION NUMBER: 0000930413-11-002543 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110403 FILED AS OF DATE: 20110405 DATE AS OF CHANGE: 20110405 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: del Campo Ralph CENTRAL INDEX KEY: 0001323683 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-12957 FILM NUMBER: 11740818 MAIL ADDRESS: STREET 1: C/O ENZON PHARMACEUTICALS INC. STREET 2: RTE 202/206 CITY: BRIDGEWATER STATE: NJ ZIP: 08807 FORMER NAME: FORMER CONFORMED NAME: delcampo ralph DATE OF NAME CHANGE: 20050413 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ENZON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000727510 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 222372868 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 685 ROUTE 202/206 CITY: BRIDGEWATER STATE: NJ ZIP: 08807 BUSINESS PHONE: 908 541 8671 MAIL ADDRESS: STREET 1: 685 ROUTE 202/206 STREET 2: ATT: GENERAL COUNSEL CITY: BRIDGEWATER STATE: NJ ZIP: 08807 FORMER COMPANY: FORMER CONFORMED NAME: ENZON PHARMACEUTICALS INC DATE OF NAME CHANGE: 20021211 FORMER COMPANY: FORMER CONFORMED NAME: ENZON PHARMACEUTICAL INC DATE OF NAME CHANGE: 20021210 FORMER COMPANY: FORMER CONFORMED NAME: ENZON INC DATE OF NAME CHANGE: 19920703 4 1 c65104.xml X0303 4 2011-04-03 0 0000727510 ENZON PHARMACEUTICALS INC ENZN 0001323683 del Campo Ralph C/O ENZON PHARMACEUTICALS INC. 685 RTE 202/206 BRIDGEWATER NJ 08807 0 1 0 0 COO and Princ. Exec. Officer Common Stock 2011-04-03 4 M 0 16800 A 175584.136 D Common Stock 2011-04-03 4 F 0 5951 11.02 D 169633.136 D Restricted Stock Units 0 2011-04-03 4 M 0 16800 D 2011-04-03 2011-04-03 Common Stock 16800 0 D Each restricted stock unit was the economic equivalent of one share of the Issuer's common stock. The reporting person settled the vested restricted stock units for shares of the Issuer's common stock. The Shares were withheld from the Reporting Person, in an exempt transaction under Rule 16b-3, solely to satisfy tax obligations arising from the vesting of the restricted stock units described in this Form 4. /s/ Andrew Rackear, Attorney-In-Fact 2011-04-05